Paolo Tarantino: Reflecting on debates in Napoli and Bridge2024
Paolo Tarantino, Research Fellow at the Dana-Farber Cancer Institute, retweeted a post by Toni Choueiri, adding the following on X:
“All the fiercest debates in history track back to Napoli:
- Maradona vs Pelé
- Pizza by Sorbillo vs Da Michele
- Best 1L IO combo.”
Quoting Toni Choueiri’s, Director of the Lank Center for GU Oncology at Dana-Farber Cancer Institute, post:
“My friend Robert Ferris from UPMC Hillman Cancer Center and UNC Lineberger was a formidable opponent in this Bridge2024 debate! Thank you Paolo A. Ascierto and Igor Puzanov for the invite to Comune Napoli and Istituto Tumori.”
Dr. Paolo Tarantino, MD, is pursuing an advanced research fellowship at Dana-Farber Cancer Institute and Harvard Medical School, concurrently working towards a PhD in clinical research at the University of Milan.
His research focuses on exploring the HER2 oncoprotein, investigating the emerging HER2-low subgroup of breast tumors, and developing novel antibody-drug conjugates targeting every subtype of breast cancer.
Toni K. Choueiri is the Director of the Lank Center for Genitourinary (GU) Oncology at Dana-Farber Cancer Institute (DFCI), co-leader of the Kidney Cancer Program at Dana-Farber/Harvard Cancer Center, and the Jerome and Nancy Kohlberg Chair and Professor of Medicine at Harvard Medical School.
As a medical oncologist, clinical trialist, and translational researcher, he specializes in treating genitourinary cancers (prostate, bladder, testis, and kidney cancer), with a focus on kidney cancer.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023